Treatment of neurological deficits in the striatum or substanta nigra pars compacta
    22.
    发明申请
    Treatment of neurological deficits in the striatum or substanta nigra pars compacta 审中-公开
    治疗纹状体或黑质神经功能缺损

    公开(公告)号:US20060069009A1

    公开(公告)日:2006-03-30

    申请号:US10952065

    申请日:2004-09-28

    IPC分类号: A61K38/18

    摘要: The present invention is directed to methods of treating neurological deficits resulting from injury or disease to the striatum or substanta nigra pars compacta of a human by administering BMP7 to the striatum or substanta nigra pars compacta of a human in amounts effective to induce cell populations having the capacity to differentiate towards a dopaminergic phenotype to in fact differentiate towards a dopaminergic phenotype, and to neurotrophic compositions and matrices suitable for use in such treatments.

    摘要翻译: 本发明涉及通过将BMP7施用于人的纹状体或黑质块状物,以有效诱导具有该细胞群的细胞群的量,将治疗由纹状体或黑质致密结构引起的损伤或疾病的神经功能缺损 区分多巴胺能表型的能力实际上分化为多巴胺能表型,以及适合用于这种治疗的神经营养组合物和基质。